Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles

Eri Katsuyama, Ph.D., M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Karampetsou MP, Comte D, Suárez-Fueyo A, Katsuyama E, Yoshida N, Kono M, Kyttaris VC, Tsokos GC. SLAMF1 engagement inhibits T cell-B cell interaction and diminishes IL-6 production and plasmablast differentiation in systemic lupus erythematosus. Arthritis Rheumatol. 2018 Jul 29. PMID: 30058241.
    View in: PubMed
  2. Katsuyama E, Yan M, Watanabe KS, Narazaki M, Matsushima S, Yamamura Y, Hiramatsu S, Ohashi K, Watanabe H, Katsuyama T, Zeggar S, Yoshida N, Moulton VR, Tsokos GC, Sada KE, Wada J. Correction: Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus-Derived T Cells. J Immunol. 2018 Aug 01; 201(3):1104. PMID: 29941662.
    View in: PubMed
  3. Ohashi K, Sada KE, Nakai Y, Matsushima S, Asano Y, Hayashi K, Yamamura Y, Hiramatsu S, Miyawaki Y, Morishita M, Katsuyama T, Katsuyama E, Watanabe H, Tatebe N, Narazaki M, Matsumoto Y, Sunahori Watanabe K, Kawabata T, Wada J. Cluster Analysis Using Anti-Aminoacyl-tRNA Synthetases and SS-A/Ro52 antibodies in Patients With Polymyositis/Dermatomyositis. J Clin Rheumatol. 2018 Jun 22. PMID: 29933322.
    View in: PubMed
  4. Miyamoto T, Hirayama A, Sato Y, Koboyashi T, Katsuyama E, Kanagawa H, Fujie A, Morita M, Watanabe R, Tando T, Miyamoto K, Tsuji T, Funayama A, Soga T, Tomita M, Nakamura M, Matsumoto M. Metabolomics-based profiles predictive of low bone mass in menopausal women. Bone Rep. 2018 Dec; 9:11-18. PMID: 29955645.
    View in: PubMed
  5. Zeggar S, Watanabe KS, Teshigawara S, Hiramatsu S, Katsuyama T, Katsuyama E, Watanabe H, Matsumoto Y, Kawabata T, Sada KE, Niki T, Hirashima M, Wada J. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model. Arthritis Rheumatol. 2018 Jul; 70(7):1089-1101. PMID: 29481735.
    View in: PubMed
  6. Suárez-Fueyo A, Bradley SJ, Katsuyama T, Solomon S, Katsuyama E, Kyttaris VC, Moulton VR, Tsokos GC. Downregulation of CD3? in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype. J Immunol. 2018 May 01; 200(9):3077-3086. PMID: 29602774.
    View in: PubMed
  7. Oya A, Katsuyama E, Morita M, Sato Y, Kobayashi T, Miyamoto K, Nishiwaki T, Funayama A, Fujita Y, Kobayashi T, Matsumoto M, Nakamura M, Kanaji A, Miyamoto T. Tumor necrosis factor receptor-associated factor 6 is required to inhibit foreign body giant cell formation and activate osteoclasts under inflammatory and infectious conditions. J Bone Miner Metab. 2017 Dec 22. PMID: 29273889.
    View in: PubMed
  8. Katsuyama E, Wakabayashi H, Sada KE, Hiramatsu S, Miyawaki Y, Morishita M, Ohashi K, Watanabe H, Katsuyama T, Zeggar S, Narazaki M, Tatebe N, Sunahori-Watanabe K, Kawabata T, Wada J. Alternative to Rituximab Therapy for a Patient with Ankylosing Spondylitis Who Was Unable to Continue Anti-TNF Therapy. Acta Med Okayama. 2017 Oct; 71(5):445-448. PMID: 29042704.
    View in: PubMed
  9. Ohashi K, Morishita M, Watanabe H, Sada KE, Katsuyama T, Miyawaki Y, Katsuyama E, Narazaki M, Tatebe N, Watanabe K, Kawabata T, Wada J. Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis. Intern Med. 2017 Nov 01; 56(21):2943-2948. PMID: 28943556.
    View in: PubMed
  10. Morishita M, Watanabe H, Yan M, Zeggar S, Hiramatsu S, Ohashi K, Miyawaki Y, Katsuyama E, Katsuyama T, Takano Narazaki M, Toyota Tatebe N, Sunahori Watanabe K, Kawabata T, Sada KE, Wada J. Azathioprine Intolerance in Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis. Intern Med. 2017; 56(13):1645-1650. PMID: 28674351.
    View in: PubMed
  11. Miyawaki Y, Katsuyama T, Sada KE, Hiramatsu S, Ohashi K, Morishita M, Katsuyama E, Watanabe H, Takano-Narazaki M, Toyota-Tatebe N, Sunahori-Watanabe K, Kawabata T, Inoue T, Kinomura M, Sugiyama H, Wada J. A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy. PLoS One. 2017; 12(5):e0178018. PMID: 28562629.
    View in: PubMed
  12. Watanabe H, Watanabe KS, Liu K, Hiramatsu S, Zeggar S, Katsuyama E, Tatebe N, Akahoshi A, Takenaka F, Hanada T, Akehi M, Sasaki T, Sada KE, Matsuura E, Nishibori M, Wada J. Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice. Mol Ther Methods Clin Dev. 2017 Sep 15; 6:31-39. PMID: 28649578.
    View in: PubMed
  13. Tatebe N, Sada KE, Asano Y, Zeggar S, Hiramatsu S, Miyawaki Y, Ohashi K, Morishita M, Katsuyama T, Katsuyama E, Watanabe H, Narazaki M, Watanabe K, Kawabata T, Wada J. Anti-SS-A/Ro antibody positivity as a risk factor for relapse in patients with polymyositis/dermatomyositis. Mod Rheumatol. 2018 Jan; 28(1):141-146. PMID: 28463039.
    View in: PubMed
  14. Katsuyama E, Yan M, Watanabe KS, Matsushima S, Yamamura Y, Hiramatsu S, Ohashi K, Watanabe H, Katsuyama T, Zeggar S, Yoshida N, Moulton VR, Tsokos GC, Sada KE, Wada J. Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus-Derived T Cells. J Immunol. 2017 06 01; 198(11):4268-4276. PMID: 28438897.
    View in: PubMed
  15. Katsuyama T, Sada KE, Yan M, Zeggar S, Hiramatsu S, Miyawaki Y, Ohashi K, Morishita M, Watanabe H, Katsuyama E, Takano-Narazaki M, Toyota-Tatebe N, Sunahori-Watanabe K, Kawabata T, Miyake K, Kiguchi T, Wada J. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents. Mod Rheumatol. 2017 Sep; 27(5):773-777. PMID: 27846761.
    View in: PubMed
  16. Miyamoto T, Hirayama A, Sato Y, Koboyashi T, Katsuyama E, Kanagawa H, Miyamoto H, Mori T, Yoshida S, Fujie A, Morita M, Watanabe R, Tando T, Miyamoto K, Tsuji T, Funayama A, Nakamura M, Matsumoto M, Soga T, Tomita M, Toyama Y. A serum metabolomics-based profile in low bone mineral density postmenopausal women. Bone. 2017 02; 95:1-4. PMID: 27989648.
    View in: PubMed
  17. Katsuyama E, Sada KE, Tatebe N, Watanabe H, Katsuyama T, Narazaki M, Sugiyama K, Watanabe KS, Wakabayashi H, Kawabata T, Wada J, Makino H. Bilateral Abducens Nerve Palsy due to Idiopathic Intracranial Hypertension as an Initial Manifestation of Systemic Lupus Erythematosus. Intern Med. 2016; 55(8):991-4. PMID: 27086818.
    View in: PubMed
  18. Miyamoto T, Katsuyama E, Kanagawa H, Fujie A, Miyamoto H, Yoshida S, Mori T, Miyamoto K, Sato Y, Kobayashi T, Nakamura M, Matsumoto M, Nishiwaki Y, Hirose H, Kanda T, Saito I, Toyama Y. Vitamin D Deficiency with High Intact PTH Levels is More Common in Younger than in Older Women: A Study of Women Aged 39-64 Years. Keio J Med. 2016 Jun 25; 65(2):33-8. PMID: 26853879.
    View in: PubMed
  19. Kanagawa H, Masuyama R, Morita M, Sato Y, Niki Y, Kobayashi T, Katsuyama E, Fujie A, Hao W, Tando T, Watanabe R, Miyamoto K, Morioka H, Matsumoto M, Toyama Y, Saya H, Miyamoto T. Methotrexate inhibits osteoclastogenesis by decreasing RANKL-induced calcium influx into osteoclast progenitors. J Bone Miner Metab. 2016 Sep; 34(5):526-31. PMID: 26202855.
    View in: PubMed
  20. Hao W, Tashiro S, Hasegawa T, Sato Y, Kobayashi T, Tando T, Katsuyama E, Fujie A, Watanabe R, Morita M, Miyamoto K, Morioka H, Nakamura M, Matsumoto M, Amizuka N, Toyama Y, Miyamoto T. Hyperglycemia Promotes Schwann Cell De-differentiation and De-myelination via Sorbitol Accumulation and Igf1 Protein Down-regulation. J Biol Chem. 2015 Jul 10; 290(28):17106-15. PMID: 25998127; PMCID: PMC4498049.
  21. Katsuyama T, Sada KE, Namba S, Watanabe H, Katsuyama E, Yamanari T, Wada J, Makino H. Risk factors for the development of glucocorticoid-induced diabetes mellitus. Diabetes Res Clin Pract. 2015 May; 108(2):273-9. PMID: 25765669.
    View in: PubMed
  22. Fujie A, Funayama A, Miyauchi Y, Sato Y, Kobayashi T, Kanagawa H, Katsuyama E, Hao W, Tando T, Watanabe R, Morita M, Miyamoto K, Kanaji A, Morioka H, Matsumoto M, Toyama Y, Miyamoto T. Bcl6 promotes osteoblastogenesis through Stat1 inhibition. Biochem Biophys Res Commun. 2015 Feb 13; 457(3):451-6. PMID: 25597995.
    View in: PubMed
  23. Katsuyama E, Miyamoto H, Kobayashi T, Sato Y, Hao W, Kanagawa H, Fujie A, Tando T, Watanabe R, Morita M, Miyamoto K, Niki Y, Morioka H, Matsumoto M, Toyama Y, Miyamoto T. Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells. J Biol Chem. 2015 Jan 09; 290(2):716-26. PMID: 25404736; PMCID: PMC4294496.
  24. Sato Y, Miyauchi Y, Yoshida S, Morita M, Kobayashi T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Tando T, Watanabe R, Miyamoto K, Morioka H, Matsumoto M, Toyama Y, Miyamoto T. The vitamin D analogue ED71 but Not 1,25(OH)2D3 targets HIF1a protein in osteoclasts. PLoS One. 2014; 9(11):e111845. PMID: 25375896; PMCID: PMC4222951.
  25. Kanagawa H, Niki Y, Kobayashi T, Sato Y, Katsuyama E, Fujie A, Hao W, Miyamoto K, Tando T, Watanabe R, Morita M, Morioka H, Matsumoto M, Toyama Y, Miyamoto T. Mycobacterium tuberculosis promotes arthritis development through Toll-like receptor 2. J Bone Miner Metab. 2015 Mar; 33(2):135-41. PMID: 24633489.
    View in: PubMed
  26. Miyauchi Y, Sato Y, Kobayashi T, Yoshida S, Mori T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Miyamoto K, Tando T, Morioka H, Matsumoto M, Chambon P, Johnson RS, Kato S, Toyama Y, Miyamoto T. HIF1a is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis. Proc Natl Acad Sci U S A. 2013 Oct 08; 110(41):16568-73. PMID: 24023068.
    View in: PubMed
  27. Niki Y, Katsuyama E, Takeda Y, Enomoto H, Toyama Y, Suda Y. Comparison of postoperative morbidity between simultaneous bilateral and staged bilateral total knee arthroplasties: serological perspective and clinical consequences. J Arthroplasty. 2014 Mar; 29(3):504-9. PMID: 23988436.
    View in: PubMed
  28. Hoshi H, Hao W, Fujita Y, Funayama A, Miyauchi Y, Hashimoto K, Miyamoto K, Iwasaki R, Sato Y, Kobayashi T, Miyamoto H, Yoshida S, Mori T, Kanagawa H, Katsuyama E, Fujie A, Kitagawa K, Nakayama KI, Kawamoto T, Sano M, Fukuda K, Ohsawa I, Ohta S, Morioka H, Matsumoto M, Chiba K, Toyama Y, Miyamoto T. Aldehyde-stress resulting from Aldh2 mutation promotes osteoporosis due to impaired osteoblastogenesis. J Bone Miner Res. 2012 Sep; 27(9):2015-23. PMID: 22508505.
    View in: PubMed
  29. Miyamoto H, Katsuyama E, Miyauchi Y, Hoshi H, Miyamoto K, Sato Y, Kobayashi T, Iwasaki R, Yoshida S, Mori T, Kanagawa H, Fujie A, Hao W, Morioka H, Matsumoto M, Toyama Y, Miyamoto T. An essential role for STAT6-STAT1 protein signaling in promoting macrophage cell-cell fusion. J Biol Chem. 2012 Sep 21; 287(39):32479-84. PMID: 22865856; PMCID: PMC3463345.
  30. Miyauchi Y, Miyamoto H, Yoshida S, Mori T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Hoshi H, Miyamoto K, Sato Y, Kobayashi T, Akiyama H, Morioka H, Matsumoto M, Toyama Y, Miyamoto T. Conditional inactivation of Blimp1 in adult mice promotes increased bone mass. J Biol Chem. 2012 Aug 17; 287(34):28508-17. PMID: 22761448; PMCID: PMC3436583.
  31. Miyamoto H, Suzuki T, Miyauchi Y, Iwasaki R, Kobayashi T, Sato Y, Miyamoto K, Hoshi H, Hashimoto K, Yoshida S, Hao W, Mori T, Kanagawa H, Katsuyama E, Fujie A, Morioka H, Matsumoto M, Chiba K, Takeya M, Toyama Y, Miyamoto T. Osteoclast stimulatory transmembrane protein and dendritic cell–specific transmembrane protein cooperatively modulate cell–cell fusion to form osteoclasts and foreign body giant cells. J Bone Miner Res. 2012 Jun; 27(6):1289-97. PMID: 22337159.
    View in: PubMed
  32. Yoshida S, Iwasaki R, Kawana H, Miyauchi Y, Hoshi H, Miyamoto H, Mori T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Kobayashi T, Sato Y, Miyamoto K, Morioka H, Matsumoto M, Chiba K, Toyama Y, Nakagawa T, Miyamoto T. PDGFBB promotes PDGFRa-positive cell migration into artificial bone in vivo. Biochem Biophys Res Commun. 2012 May 18; 421(4):785-9. PMID: 22554514.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Katsuyama's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (171)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_